BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11207394)

  • 1. Modulation of neuronal activity in the nucleus raphé magnus by the 5-HT(1)-receptor agonist naratriptan in rat.
    Ellrich J; Messlinger K; Chiang CY; Hu JW
    Pain; 2001 Feb; 90(3):227-231. PubMed ID: 11207394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical neuropharmacology of naratriptan.
    Lambert GA
    CNS Drug Rev; 2005; 11(3):289-316. PubMed ID: 16389295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons.
    Donaldson C; Boers PM; Hoskin KL; Zagami AS; Lambert GA
    Neuropharmacology; 2002 Mar; 42(3):374-85. PubMed ID: 11897116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naratriptan has a selective inhibitory effect on trigeminovascular neurones at central 5-HT1A and 5-HT(1B/1D) receptors in the cat: implications for migraine therapy.
    Boers PM; Donaldson C; Zagami AS; Lambert GA
    Cephalalgia; 2004 Feb; 24(2):99-109. PubMed ID: 14728705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors.
    Goadsby PJ; Knight Y
    Br J Pharmacol; 1997 Nov; 122(5):918-22. PubMed ID: 9384509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation by serotonin of the neurons in rat nucleus raphe magnus in vitro.
    Pan ZZ; Wessendorf MW; Williams JT
    Neuroscience; 1993 May; 54(2):421-9. PubMed ID: 8101640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacy-clinic medication of the month. Naratriptan (naramig)].
    Scheen AJ
    Rev Med Liege; 1999 Mar; 54(3):189-91. PubMed ID: 10321110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
    Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of the 5HT1B/1D receptor agonist naratriptan on trigeminal versus spinal nociceptive responses.
    Cumberbatch MJ; Hill RG; Hargreaves RJ
    Cephalalgia; 1998 Dec; 18(10):659-63. PubMed ID: 9950621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naratriptan: an alternative for migraine.
    Dulli DA
    Ann Pharmacother; 1999 Jun; 33(6):704-11. PubMed ID: 10410185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat.
    Hoskin KL; Lambert GA; Donaldson C; Zagami AS
    Brain Res; 2004 Feb; 998(1):91-9. PubMed ID: 14725972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naratriptan.
    Massiou H
    Curr Med Res Opin; 2001; 17 Suppl 1():s51-3. PubMed ID: 12463278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT4 receptors exert a frequency-related facilitatory control on dorsal raphé nucleus 5-HT neuronal activity.
    Lucas G; Debonnel G
    Eur J Neurosci; 2002 Sep; 16(5):817-22. PubMed ID: 12372017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target?
    Shields KG; Goadsby PJ
    Neurobiol Dis; 2006 Sep; 23(3):491-501. PubMed ID: 16875831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoregulatory properties of dorsal raphe 5-HT neurons: possible role of electrotonic coupling and 5-HT1D receptors in the rat brain.
    Piñeyro G; de Montigny C; Weiss M; Blier P
    Synapse; 1996 Jan; 22(1):54-62. PubMed ID: 8822478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.
    Bomhof M; Paz J; Legg N; Allen C; Vandormael K; Patel K
    Eur Neurol; 1999; 42(3):173-9. PubMed ID: 10529545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local GABA-ergic modulation of serotonergic neuron activity in the nucleus raphe magnus].
    Iniushkin AN; Merkulova NA; Orlova AO; Iniushkina EM
    Ross Fiziol Zh Im I M Sechenova; 2009 Jul; 95(7):750-61. PubMed ID: 19803461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Femoxetine blocks the morphine-induced increase in 5-HT metabolism, as measured by in vivo voltammetry in the nucleus raphe magnus of freely-moving rats.
    Puig S; Rivot JP; Besson JM
    Neuropharmacology; 1991 Oct; 30(10):1053-8. PubMed ID: 1722031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain.
    Adell A; Celada P; Artigas F
    J Neurochem; 2001 Oct; 79(1):172-82. PubMed ID: 11595769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naratriptan.
    Salonen R
    Int J Clin Pract; 1999; 53(7):552-6. PubMed ID: 10692743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.